Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Endocrine 2Thoracic 1Genitourinary 1CNS 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 9Squamous Cell Carcinoma of Head and Neck 8Esthesioneuroblastoma, Olfactory 8Breast Neoplasms 8Head and Neck Neoplasms 7Salivary Gland Neoplasms 6Lung Neoplasms 6Urinary Bladder Neoplasms 5Prostatic Neoplasms 5Esophageal Neoplasms 5Stomach Neoplasms 4Small Cell Lung Carcinoma 4Ovarian Neoplasms 4Carcinoma, Ovarian Epithelial 4Sarcoma 3Osteosarcoma 3Neuroectodermal Tumors, Primitive, Peripheral 3Breast Neoplasms, Male 3Sarcoma, Kaposi 2Rectal Neoplasms 2Pancreatic Neoplasms 2Neuroblastoma 2Nasopharyngeal Neoplasms 2Melanoma 2Medulloblastoma 2Glioma 2Colonic Neoplasms 2Chondrosarcoma 2Carcinoma, Renal Cell 2Brain Neoplasms 2

Interventions

trametinib 2dabrafenib 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1sargramostim 1cobimetinib 1cabozantinib 1atezolizumab 1aldesleukin 1Vemurafenib 1Trastuzumab 1Tamoxifen 1Semaxinib 1Radiotherapy 1Paclitaxel 1Gefitinib 1Doxorubicin 1Docetaxel 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Carcinoma, Anaplastic × Docetaxel × CNS × Clear all
NCT00937417 2017-04-24

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

SWOG Cancer Research Network

Phase 1 Withdrawn
BreastCNSEndocrineGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Breast Neoplasms, Male, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡